IMA vs JNJ: Which Stock is Better?
Side-by-side comparison of Imagenebio Inc and Johnson & Johnson in 2026
IMA
Imagenebio Inc
$4.90
JNJ
Johnson & Johnson
$240.16
Key Metrics Comparison
| Metric | IMA | JNJ | Winner |
|---|---|---|---|
| Market Cap | $54.83M | $573.46B | JNJ |
| P/E Ratio | N/A | 21.55 | JNJ |
| EPS (TTM) | $N/A | $11.04 | JNJ |
| Revenue Growth | 0.0% | 0.1% | JNJ |
| Gross Margin | 100.0% | 68.1% | IMA |
Analyze IMA
Full quant analysis
Analyze JNJ
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IMA or JNJ a better investment?
Comparing IMA and JNJ: Imagenebio Inc has a market cap of $54.83M while Johnson & Johnson has $573.46B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IMA and JNJ?
IMA (Imagenebio Inc) and JNJ (Johnson & Johnson) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IMA or JNJ?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IMA or JNJ?
JNJ has higher revenue growth at 0.1% vs 0.0% for IMA.
Which company is more profitable: IMA or JNJ?
Imagenebio Inc (IMA) has higher gross margins at 100.0% compared to 68.1% for JNJ.
Which is the larger company: IMA or JNJ?
Johnson & Johnson (JNJ) is larger with a market cap of $573.46B compared to $54.83M for IMA.
Should I buy IMA or JNJ in 2026?
Both IMA and JNJ have investment merit. IMA trades at $4.90 while JNJ trades at $240.16. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IMA and JNJ stock?
Key differences: Market Cap ($54.83M vs $573.46B), P/E Ratio (N/A vs 21.6x), Revenue Growth (0.0% vs 0.1%), Gross Margin (100.0% vs 68.1%).